MBX Biosciences (MBX) Insider Trading & Ownership $14.85 +0.58 (+4.06%) As of 03:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock MBX Biosciences (NYSE:MBX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage52.19%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$20.60MNumber OfInsiders Selling(Last 12 Months)0 Get MBX Insider Trade Alerts Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBX Insider Buying and Selling by Quarter MBX Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/8/2025Ora H PescovitzDirectorBuy7,693$5.89$45,311.77 2/18/2025Carl L GordonDirectorBuy143,170$10.84$1,551,962.80 2/14/2025Carl L GordonDirectorBuy47,502$9.87$468,844.74 2/4/2025P. Kent HawrylukCEOBuy50,000$10.69$534,500.00 9/16/2024Edward T MathersDirectorBuy500,000$16.00$8,000,000.00 9/16/2024Life Sciences X L.P. FrazierMajor ShareholderBuy625,000$16.00$10,000,000.00 (Data available from 1/1/2013 forward) MBX Insider Trading Activity - Frequently Asked Questions Who is on MBX Biosciences' Insider Roster? The list of insiders at MBX Biosciences includes Carl L Gordon, Edward T Mathers, Life Sciences X L.P. Frazier, Ora H Pescovitz, and P. Kent Hawryluk. Learn more on insiders at MBX. What percentage of MBX Biosciences stock is owned by insiders? 52.19% of MBX Biosciences stock is owned by insiders. Learn more on MBX's insider holdings. Which MBX Biosciences insiders have been buying company stock? The following insiders have purchased MBX shares in the last 24 months: Carl L Gordon ($2,020,807.54), Edward T Mathers ($8,000,000.00), Life Sciences X L.P. Frazier ($10,000,000.00), Ora H Pescovitz ($45,311.77), and P. Kent Hawryluk ($534,500.00). How much insider buying is happening at MBX Biosciences? Insiders have purchased a total of 1,373,365 MBX shares in the last 24 months for a total of $20,600,619.31 bought. MBX Biosciences Key ExecutivesMr. Peter Kent Hawryluk (Age 55)CEO, President & Director Compensation: $571.2kDr. Steven J. Prestrelski M.B.A. (Age 60)MBA, Ph.D., Chief Scientific Officer Mr. Matt GambinoVice President of MarketingMs. Michelle Graham (Age 57)Chief Human Resources Officer Dr. Salomon Azoulay (Age 67)Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Adaptive Biotechnologies Insider Trading Vericel Insider Trading Dyne Therapeutics Insider Trading Beam Therapeutics Insider Trading Apogee Therapeutics Insider Trading Immunocore Insider Trading Twist Bioscience Insider Trading Biohaven Insider Trading Travere Therapeutics Insider Trading Cidara Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NYSE:MBX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access